Subject:  Re Agrylin and ES (fwd)
Date:     Wed, 13 May 1998 141429 -0500 (CDT)
From:     "Roy L. Beavers" <rbeavers@llion.org>
To:       emfguru@hotmail.com
--------------------------------------------------


---------- Forwarded message ----------
Date: Wed, 13 May 1998 17:56:21 +0200
From: Per Dalen 
To: "Roy L. Beavers" 
Cc: vgv@isholf.is
Subject: Re: Agrylin and ES (fwd)

At 10:23 6-4-98 -0500, Valdemar Gisli Valdemarsson wrote:

>I would like to know if anyone is familiar with the medicine AGRYLIN.
>(anagrelide hydrochloride) Agrylin is a new medicine prescribed to treat
>patients with Essential Thrombocythemia to lower the count of platelet in
>the blood.
>I ask because one ET-patient contacted me and described side effects which
>I found extreemly similiar to electric sensitivity.  In information brocure
>about the medicine, which is produced by Roberts Pharmaceutical
>Corporation, it is informed that most common side effects include headache,
>fast heartbeat, diarrhea, weakness, pain in the abdomen, nausea, dizziness
>and shortness of breath.
>What is most interesting is that this patient livies near by a LW masts and
>TV/FM tower. Her surroundings are highly saturated with RF waves.  Since
>she started to take this medicine she can't tolerate to go out for a walk
>in her neigborhood.  Every time she walks she feels something like electric
>pulses in her feets.  She is also feeling stress and tension.  But when she
>goes for a stroll far away from the tower she does not feel those symtoms.
>The stress and tension is less and this electric pulse in her feet is not a
>problem.
>In the brochure it is stated that side effects can be; for the whole body
>system,: Fever, flu symtoms, chils, neck pain and photosensitivity.
>
>HOW IT Works:
>Anagrelide is a quinazoline derivative that is structurally similar to
>ketanserin (an antiaggregant and antihypertensive), methaqualone (a central
>nervous system depressant, metolazone (an antihypertensive saluretic), and
>prazosin (an antihypertensive. It is a powerful platelet antiaggregant. It
>appears to inhibit cyclic nucleotide phospholisterase and the release of
>arachidonic acid from phospholipase, possibly by inhibiting phospholipase.
>It also causes a dose-related reduction in platelet production, which
>results from decreased megakaryocyte hypermaturation. The drug disrupts the
>postmitotic phase of maturation.
>
>Is it possible that this medicine also triggers Electric Sensitivity?
>
>Valdemar Gisli Valdemarsson
>Iceland
>Phone: 354-896-6110
>email: vgv@isholf.is
>Internet:   http://www.isholf.is/vgv
>***********************************************************************
<[Roy's comments:]>
>Valdemar:
>
>I'm sure you realize we are again in the "anecdotal info" arena.
>As I have said before, some of these anecdotal experiences need to 
>be checked out.  Science often gets its ideas from such experiences.
>I have often wondered if it is just legend that the apple fell on
>the head of one prescient observor (Newton) who consequently discovered 
>gravity -- an anecdotal experience....


Sorry not to have responded before, because this is very, very interesting.
I am not at all familiar with Agrylin, but never mind. The important thing
is the intriguing possibility that a known chemical substance might
sometimes (one case so far) make you sensitive to electrical phenomena. A
syndrome that "doesn't exist" is released by a registered drug! In a
detective story this would be the No. 1 clue, but as we know, scientists
may be too conservative for this kind of thinking. 

The story about Newton and the apple may be apocryphal, but only a high
priest of modern science would be silly enough to suggest that similar
experiences should be disregarded because they are anecdotal. When
curiosity and the spirit of discovery has been subordinated to the
mechanical insistence on due process it is time to stop putting your money
on science ;-).

Cheers,

Per
Per Dalen 



Archive provided courtesy of WaveGuide, http://www.wave-guide.org
Reprinted with permission of Roy Beavers, http://www.feb.se/EMF-L/EMF-L.html